Vir Biotechnology COO Johanna Friedl-Naderer to depart Sept 29; role not replaced

Vir Biotechnology, Inc.

EVP and COO Johanna Friedl-Naderer will leave Vir Biotechnology on September 29, 2023.
The COO role will not be filled; responsibilities assigned to other management team members.
No successor has been named for the departing officer.
Departure announced September 20, 2023, effective shortly thereafter.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Johanna Friedl-Naderer

Executive Vice President and Chief Operating Officer

VIR · Vir Biotechnology, Inc.

Effective: 2023-09-29
Filed: September 20, 2023, 7:59 PM ET

On September 20, 2023, Vir Biotechnology, Inc. (the “Company”) announced that Johanna Friedl-Naderer, the Company’s Executive Vice President and Chief Operating Officer, will be leaving the Company on September 29, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Johanna Friedl-Naderer departed as Executive Vice President and Chief Operating Officer at Vir Biotechnology, Inc..

Action: leaving
Role: Executive Vice President and Chief Operating Officer

Exact text from the filing

On September 20, 2023, Vir Biotechnology, Inc. (the “Company”) announced that Johanna Friedl-Naderer, the Company’s Executive Vice President and Chief Operating Officer, will be leaving the Company on September 29, 2023.

View on SEC.gov

Vir Biotechnology, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-23-237943

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.